Internal Medicine · Buffalo, NY
NPI
1598712754
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
462 Grider St
Buffalo, NY, 14215
Phone (716) 898-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,039
74 services
Medicare patients, 2024
54
Average age 61
Drug cost, 2024
$1.8M
1,288 prescriptions
Company payments, 2025
$385K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony D Martinez was code 99214 (office e&m - established), 61 times for 46 patients. In total Anthony D Martinez billed 74 services in 5 codes, and Medicare paid $5,039.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 61 | 46 | $70.23 | $4,284 |
By year: 2022 $11K for 201 services; 2023 $9,288 for 186 services; 2024 $5,039 for 74 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anthony D Martinez prescribed most often to Medicare patients was Xifaxan (Rifaximin), with 124 prescriptions and refills. In total Anthony D Martinez wrote 1,288 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xifaxan Rifaximin | 124 | 124 | 18 | $397K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 112 | 113 | 15 | $24K |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 67 | 67 | Under 11 | $49K |
| Furosemide Generic | 64 | 78 | 14 | $175 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 57 | 57 | Under 11 | $230K |
| Pantoprazole Sodium Generic | 56 | 82 | 11 | $735 |
| Ursodiol Generic | 48 | 76 | Under 11 | $9,709 |
| Buprenorphine Hcl Generic | 46 | 46 | Under 11 | $2,900 |
| Entecavir Generic | 35 | 51 | Under 11 | $2,476 |
| Spironolactone Generic | 33 | 75 | Under 11 | $468 |
| Azathioprine Generic | 32 | 56 | Under 11 | $1,081 |
| Omeprazole Generic | 32 | 32 | Under 11 | $167 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 29 | 29 | Under 11 | $145 |
| Lactulose Generic | 28 | 33 | Under 11 | $1,520 |
| Valacyclovir Valacyclovir Hcl | 25 | 25 | Under 11 | $443 |
Brand drugs: 356 claims; generic drugs: 932 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony D Martinez $385K ($385K in general payments such as food, travel and fees) from 9 companies. The largest payer was Madrigal Pharmaceuticals with $183K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 134 | $183K |
| Abbvie Inc. ABBV | 76 | $90K |
| Gilead Sciences, Inc. GILD | 79 | $75K |
| Novo Nordisk Inc NVO | 7 | $15K |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 8 | $11K |
| Cepheid DHR | 2 | $5,500 |
| Braeburn Inc. | 4 | $4,543 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 12 | $136 |
| Orexo US, Inc. | 1 | $16.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.